Cargando…
Oncologic and Reproductive Outcomes of Uterine Smooth Muscle Tumor of Uncertain Malignant Potential: A Single Center Retrospective Study of 67 Cases
Background: The term “uterine smooth muscle tumor of uncertain malignant potential” (STUMP) indicates a rare tumor that cannot be classified as a benign leiomyoma or malignant leiomyosarcoma. In this study, we assessed the clinical characteristics, fertility, and oncologic outcomes of patients diagn...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7240040/ https://www.ncbi.nlm.nih.gov/pubmed/32477938 http://dx.doi.org/10.3389/fonc.2020.00647 |
_version_ | 1783536801108983808 |
---|---|
author | Huo, Lanqing Wang, Dan Wang, Wenze Cao, Dongyan Yang, Jiaxin Wu, Ming Yang, Junjun Xiang, Yang |
author_facet | Huo, Lanqing Wang, Dan Wang, Wenze Cao, Dongyan Yang, Jiaxin Wu, Ming Yang, Junjun Xiang, Yang |
author_sort | Huo, Lanqing |
collection | PubMed |
description | Background: The term “uterine smooth muscle tumor of uncertain malignant potential” (STUMP) indicates a rare tumor that cannot be classified as a benign leiomyoma or malignant leiomyosarcoma. In this study, we assessed the clinical characteristics, fertility, and oncologic outcomes of patients diagnosed as STUMP in 14 years. In addition, we analyzed the risk factors for recurrence in patients with STUMP. Methods: Medical records of STUMP patients at Peking Union Medical College Hospital (PUMCH) between January 2005 and June 2019 were reviewed and analyzed. Disease-free survival, age of diagnosis, tumor size, surgical procedure, pathology and immunohistochemistry, clinical characteristics, recurrence rate, and reproductive outcomes in the follow-up period were assessed. Univariate and multivariate analyses were performed to determine the prognostic factors. Results: The median age was 42 years old (range: 21–63). Total hysterectomy with or without bilateral salpingo-oophorectomy was performed in 29/67 cases (43.3%), and myomectomy was performed in 38/67 cases (56.7%). Ten patients experienced recurrences, and all but two recurrences occurred within 5 years after the initial surgery. Only two of these recurrences were leiomyosarcoma. There were no deaths in the median follow-up period of 48.4 (range 2.6–170.2) months. There were no remarkable differences in location of tumor between the myomectomy and hysterectomy groups, but the patients in the myomectomy group were younger than those in the hysterectomy group. In univariate and multivariate analysis, mitosis on pathology was the only independent risk factor for recurrence. Expression of Ki-67, p53, and p16 was significantly higher in patients with recurrence. Seven of the 35 patients who attempted to conceive had successful pregnancies. Conclusions: The prognosis of STUMP was favorable and tumors with more than 10 mitoses per 10 high power field should be monitored closely. The surgical procedure was not an independent risk factor of recurrence, and myomectomy may be an acceptable option for patients wishing to preserve fertility. |
format | Online Article Text |
id | pubmed-7240040 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-72400402020-05-29 Oncologic and Reproductive Outcomes of Uterine Smooth Muscle Tumor of Uncertain Malignant Potential: A Single Center Retrospective Study of 67 Cases Huo, Lanqing Wang, Dan Wang, Wenze Cao, Dongyan Yang, Jiaxin Wu, Ming Yang, Junjun Xiang, Yang Front Oncol Oncology Background: The term “uterine smooth muscle tumor of uncertain malignant potential” (STUMP) indicates a rare tumor that cannot be classified as a benign leiomyoma or malignant leiomyosarcoma. In this study, we assessed the clinical characteristics, fertility, and oncologic outcomes of patients diagnosed as STUMP in 14 years. In addition, we analyzed the risk factors for recurrence in patients with STUMP. Methods: Medical records of STUMP patients at Peking Union Medical College Hospital (PUMCH) between January 2005 and June 2019 were reviewed and analyzed. Disease-free survival, age of diagnosis, tumor size, surgical procedure, pathology and immunohistochemistry, clinical characteristics, recurrence rate, and reproductive outcomes in the follow-up period were assessed. Univariate and multivariate analyses were performed to determine the prognostic factors. Results: The median age was 42 years old (range: 21–63). Total hysterectomy with or without bilateral salpingo-oophorectomy was performed in 29/67 cases (43.3%), and myomectomy was performed in 38/67 cases (56.7%). Ten patients experienced recurrences, and all but two recurrences occurred within 5 years after the initial surgery. Only two of these recurrences were leiomyosarcoma. There were no deaths in the median follow-up period of 48.4 (range 2.6–170.2) months. There were no remarkable differences in location of tumor between the myomectomy and hysterectomy groups, but the patients in the myomectomy group were younger than those in the hysterectomy group. In univariate and multivariate analysis, mitosis on pathology was the only independent risk factor for recurrence. Expression of Ki-67, p53, and p16 was significantly higher in patients with recurrence. Seven of the 35 patients who attempted to conceive had successful pregnancies. Conclusions: The prognosis of STUMP was favorable and tumors with more than 10 mitoses per 10 high power field should be monitored closely. The surgical procedure was not an independent risk factor of recurrence, and myomectomy may be an acceptable option for patients wishing to preserve fertility. Frontiers Media S.A. 2020-05-14 /pmc/articles/PMC7240040/ /pubmed/32477938 http://dx.doi.org/10.3389/fonc.2020.00647 Text en Copyright © 2020 Huo, Wang, Wang, Cao, Yang, Wu, Yang and Xiang. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Huo, Lanqing Wang, Dan Wang, Wenze Cao, Dongyan Yang, Jiaxin Wu, Ming Yang, Junjun Xiang, Yang Oncologic and Reproductive Outcomes of Uterine Smooth Muscle Tumor of Uncertain Malignant Potential: A Single Center Retrospective Study of 67 Cases |
title | Oncologic and Reproductive Outcomes of Uterine Smooth Muscle Tumor of Uncertain Malignant Potential: A Single Center Retrospective Study of 67 Cases |
title_full | Oncologic and Reproductive Outcomes of Uterine Smooth Muscle Tumor of Uncertain Malignant Potential: A Single Center Retrospective Study of 67 Cases |
title_fullStr | Oncologic and Reproductive Outcomes of Uterine Smooth Muscle Tumor of Uncertain Malignant Potential: A Single Center Retrospective Study of 67 Cases |
title_full_unstemmed | Oncologic and Reproductive Outcomes of Uterine Smooth Muscle Tumor of Uncertain Malignant Potential: A Single Center Retrospective Study of 67 Cases |
title_short | Oncologic and Reproductive Outcomes of Uterine Smooth Muscle Tumor of Uncertain Malignant Potential: A Single Center Retrospective Study of 67 Cases |
title_sort | oncologic and reproductive outcomes of uterine smooth muscle tumor of uncertain malignant potential: a single center retrospective study of 67 cases |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7240040/ https://www.ncbi.nlm.nih.gov/pubmed/32477938 http://dx.doi.org/10.3389/fonc.2020.00647 |
work_keys_str_mv | AT huolanqing oncologicandreproductiveoutcomesofuterinesmoothmuscletumorofuncertainmalignantpotentialasinglecenterretrospectivestudyof67cases AT wangdan oncologicandreproductiveoutcomesofuterinesmoothmuscletumorofuncertainmalignantpotentialasinglecenterretrospectivestudyof67cases AT wangwenze oncologicandreproductiveoutcomesofuterinesmoothmuscletumorofuncertainmalignantpotentialasinglecenterretrospectivestudyof67cases AT caodongyan oncologicandreproductiveoutcomesofuterinesmoothmuscletumorofuncertainmalignantpotentialasinglecenterretrospectivestudyof67cases AT yangjiaxin oncologicandreproductiveoutcomesofuterinesmoothmuscletumorofuncertainmalignantpotentialasinglecenterretrospectivestudyof67cases AT wuming oncologicandreproductiveoutcomesofuterinesmoothmuscletumorofuncertainmalignantpotentialasinglecenterretrospectivestudyof67cases AT yangjunjun oncologicandreproductiveoutcomesofuterinesmoothmuscletumorofuncertainmalignantpotentialasinglecenterretrospectivestudyof67cases AT xiangyang oncologicandreproductiveoutcomesofuterinesmoothmuscletumorofuncertainmalignantpotentialasinglecenterretrospectivestudyof67cases |